183 related articles for article (PubMed ID: 19928493)
1. [Evaluation of the factor which has an influence on red blood cell deformability in patients with end-stage renal disease].
Tateishi K; Fujita J; Taminato T
Rinsho Byori; 2009 Oct; 57(10):965-70. PubMed ID: 19928493
[TBL] [Abstract][Full Text] [Related]
2. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
[TBL] [Abstract][Full Text] [Related]
3. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of phosphatydilcholine-hydroperoxide in dialysis patients with diabetic nephropathy.
Sanaka T; Takahashi C; Sanaka M; Higuchi C; Shinobe M; Hayasaka Y; Miyazawa T; Ishikawa S; Nihei H; Omori Y
Clin Nephrol; 1995 Nov; 44 Suppl 1():S33-7. PubMed ID: 8608660
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic kidney disease on red blood cell rheology.
Brimble KS; McFarlane A; Winegard N; Crowther M; Churchill DN
Clin Hemorheol Microcirc; 2006; 34(3):411-20. PubMed ID: 16614465
[TBL] [Abstract][Full Text] [Related]
7. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
Abe M; Kaizu K; Matsumoto K
Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of heart rate variability entropy and blood pressure during hemodialysis in patients with end-stage renal disease.
Yamanaka N; Aoyama T; Ikeda N; Higashihara M; Kamata K
Hemodial Int; 2005 Jul; 9(3):303-8. PubMed ID: 16191081
[TBL] [Abstract][Full Text] [Related]
10. Coagulation abnormalities in diabetic patients undergoing renal transplantation.
Reissell E; Lalla M; Höckerstedt K; Lindgren L
Ann Chir Gynaecol; 1994; 83(3):251-5. PubMed ID: 7857071
[TBL] [Abstract][Full Text] [Related]
11. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
12. Skin blood flow in patients with stage 5 chronic kidney disease on hemodialysis.
Ngo B; Rongey C; Hiscox B; Rendell M; Woodley D; Smogorzewski M
J Ren Nutr; 2010 Sep; 20(5 Suppl):S89-94. PubMed ID: 20797579
[TBL] [Abstract][Full Text] [Related]
13. Effect of end-stage renal disease on responsiveness to calmodulin and thyroid hormone of calcium-ATPase in human red blood cells.
Nieman LK; Davis FB; Davis PJ; Cunningham EE; Gutman S; Blas SD; Schoenl M
Kidney Int Suppl; 1983 Dec; 16():S167-70. PubMed ID: 6234422
[TBL] [Abstract][Full Text] [Related]
14. Study of red blood cell (RBC) deformability in hemodialysis (HD) patients.
Turci F; Docci D; Salvi G; Salvi P; Zoli I; Battistini G; Pretolani E
Life Support Syst; 1983; 1 Suppl 1():211-4. PubMed ID: 6336413
[No Abstract] [Full Text] [Related]
15. [Disturbance of the autonomic nerve system in patients with chronic renal failure--represented by variation coefficient of R-R intervals in the ECG as a parameter].
Oda K; Nagayama N; Ohtsubo Y; Ohashi T; Hagihara R; Uomizu K; Yamashita W; Nakashima A; Harada R; Arima T
Fukuoka Igaku Zasshi; 1990 Feb; 81(2):71-6. PubMed ID: 2328937
[TBL] [Abstract][Full Text] [Related]
16. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
17. Pulse wave velocity in end-stage renal disease: influence of age and body dimensions.
Kis E; Cseprekál O; Horváth Z; Katona G; Fekete BC; Hrapka E; Szabó A; Szabó AJ; Fekete A; Reusz GS
Pediatr Res; 2008 Jan; 63(1):95-8. PubMed ID: 18043514
[TBL] [Abstract][Full Text] [Related]
18. An altered TH1/TH2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology.
Sui W; Tan J; Guo J; Du G; Dai Y
Ren Fail; 2009; 31(1):1-5. PubMed ID: 19142802
[TBL] [Abstract][Full Text] [Related]
19. Deformability and enzymes activities of red blood cells in hemodialysed and peritoneal dialysed patients with chronic renal disease.
Nowak-Piszczek E; Wyrwicz G; Dabrowski Z; Smoleński O; Spodaryk K
Clin Hemorheol Microcirc; 2003; 28(4):251-7. PubMed ID: 12897415
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic ionized magnesium concentration in end-stage renal disease. Effect of hemodialysis.
Kaupke CJ; Zhou XJ; Vaziri ND
ASAIO J; 1993; 39(3):M614-7. PubMed ID: 8268611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
